Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameAustar
Stock Code06118
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是一家在中國領先的高端綜合服務及產品一體化工程解決方案供應商,面向在中國的知名製藥企業及研究機構,亦在新興國家向客戶提供此等服務和產品。解決方案涵蓋流體與生物工藝系統、潔淨室及自動化控制與監控系統、粉體固體系統及GMP合規性服務,並從事高端製藥設備及生命科技耗材的製造、銷售及分銷。
Listing Date2014-11-07
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)北京市朝陽區朝外大街26號朝外門寫字中心B座1801室
Business Address (Hong Kong)香港新界沙田安平街6號新貿中心1樓6室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.austar.com.hk
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 3.12 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2014-10-28 to 2014-10-31
Global Offering Shares125,000,000 shares
HK Public Offer Shares (Initial)12,500,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)112,500,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO500,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 390,000,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 359.8M
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +2600%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣53.6百萬元
Period-End Cash Balance人民幣139.7百萬元
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 2011201220132014-06
Revenue 325,178420,753705,153320,823
Cost of sales -224,657-284,304-490,187-207,086
Gross profit 100,521136,449214,966113,737
Other income and gains, net 3054181,130590
Selling and distribution expenses -28,528-36,760-72,104-32,374
Administrative expenses -24,502-35,383-47,849-30,568
Operating profit 36,45148,48572,20040,572
Net finance costs -684-1,301-42303
Share of associates and JVs 2,6314,1024,4952,579
Profit before tax 38,39851,28676,65343,454
Income tax expense -11,061-15,777-23,082-10,705
Profit for the year 27,33735,50953,57132,749
Profit attributable to owners 27,25835,47653,57132,750
Balance Sheet
Item 2011201220132014-06
Cash and cash equivalents 37,499102,611139,71252,346
Trade and bills receivables 122,348174,618201,507241,557
Inventories 54,58649,00874,55065,197
Total current assets 250,596377,853537,474481,313
Total assets 299,893437,053606,853555,707
Total current liabilities 238,878357,446466,199337,362
Total liabilities 242,623364,464478,478349,070
Total equity 57,27072,589128,375206,637
Equity attributable to owners 56,97672,587128,374206,636
Interest-bearing borrowings 24,00024,00020,00035,000
Cash Flow Statement
Item 2011201220132014-06
Net cash from operating activities 16,91873,98171,407-84,571
Net cash from investing activities -7,165-24,759-44,54917,589
Net cash from financing activities 5,14816,88610,254-20,373
Net increase in cash 14,90166,10837,112-87,355
Purchase of PP&E -6,548-5,950-11,049-7,159
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 3.57
First Day OpenHK$ 3.85
First Day Change14.42%
First Day Volume130979000.0
First Day Turnover489046000.0
Use of Proceeds
1、約39.6%或134.4百萬港元將用于成立石家莊研發與制造中心,其中: 1.1 約9.2%或31.1百萬港元將用于收購土地; 1.2 約20.4%或69.3百萬港元將用于為生產設施的開發及建設成本提供資金; 1.3 約9.1%或30.8百萬港元將用于為粉體固體系統應用中心以及流體工藝應用中心的開發及建設成本以及設備采購成本提供資金; 1.4 約0.9%或3.1百萬港元將用于為生產廠房購買設備。 2、約14.2%或48.2百萬港元將用于為松江制造中心的開發提供資金,其中: 2.1約13.8%或46.7百萬港元將用于為生產設施的建設提供資金; 2.2約0.4%或1.5百萬港元將用于購買設備。 3、約6.8%或23.1百萬港元將用于通過為銷售及市場推廣團隊聘用額外雇員、為加強市場滲透成立額外代表辦事處及開展市場推廣活動(如組織及出席研討會、展覽會及會議)擴展銷售及市場推廣網絡; 4、約9.5%或32.1百萬港元將用于為研發活動提供資金,包括增加研發團隊人員數目的成本及研發項目投資; 5、約20.0%或67.9百萬港元將用于收購我們未來可能于中國、北美或歐洲物色的于制藥設備、工藝系統及服務市場擁有關鍵產品技術的公司之權益; 6、約9.9%或33.7百萬港元將用作營運資金及其他一般公司用途。

Underwriting Syndicate

Sole Sponsor (1)
海通国际资本有限公司 CE ADQ859
Overall Coordinators (1)
海通国际证券有限公司 CE AAF806
Joint Bookrunners (2)
海通国际证券有限公司 CE AAF806 交银国际证券有限公司 CE APJ121
Joint Lead Managers (3)
海通国际证券有限公司 CE AAF806 交银国际证券有限公司 CE APJ121 KGI CAPITAL ASIA LIMITED CE ADT039

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman何國強—
Company Secretary陳煒聰—
No director data available.

Major Shareholders

Major Shareholders & Holdings何國強先生(通過SFH)持有66.75%,顧女士(通過HCV)持有0.75%,合共67.50%;何建紅先生(通過TWG)持有7.50%。
About this page

This page shows Austar (06118) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect